Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus/Everolimus vs. Tacrolimus/EC-MPS in Kidney Transplantation
NCT01680861Phase 3Completed
- Start
- Nov 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in kidney failure (ESRD), kidney transplant rejection. Started Nov 2012; status: completed.
02
Drugs
everolimus
03
Conditions
kidney failure (ESRD)kidney transplant rejection
Beyond the preview
Go deeper on NCT01680861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680861.